Literature DB >> 14658714

Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis.

Albert J Mohr1, Andrew L Leisewitz, Linda S Jacobson, Jörg M Steiner, Craig G Ruaux, David A Williams.   

Abstract

A randomized, controlled clinical trial investigated the effect of early enteral nutrition (EN) on intestinal permeability, intestinal protein loss, and outcome in parvoviral enteritis. Dogs were randomized into 2 groups: 15 dogs received no food until vomiting had ceased for 12 hours (mean 50 hours after admission; NPO group), and 15 dogs received early EN by nasoesophageal tube from 12 hours after admission (EEN group). All other treatments were identical. Intestinal permeability was assessed by 6-hour urinary lactulose (L) and rhamnose (R) recoveries (%L, %R) and L/R recovery ratios. Intestinal protein loss was quantified by fecal alpha1-proteinase inhibitor concentrations (alpha1-PI). Median time to normalization of demeanor, appetite, vomiting, and diarrhea was 1 day shorter for the EEN group for each variable. Body weight increased insignificantly from admission in the NPO group (day 3: 2.5 +/- 2.8%; day 6: 4.3 +/- 2.3%; mean +/- SE), whereas the EEN group exhibited significant weight gain (day 3: 8.1 +/- 2.7%; day 6: 9.7 +/- 2.1%). Mean urinary %L was increased, %R reduced, and L/R recovery ratios increased compared to reference values throughout the study for both groups. Percent lactulose recovery decreased in the EEN group (admission: 22.6 +/- 8.0%; day 6: 17.9 +/- 2.3%) and increased in the NPO group (admission: 11.0 +/- 2.6%; day 6: 22.5 +/- 4.6%, P = .035). Fecal alpha1-PI was above reference values in both groups and declined progressively. No significant differences occurred for %R, L/R ratios, or alpha1-PI between groups. Thirteen NPO dogs and all EEN dogs survived (P = .48). The EEN group showed earlier clinical improvement and significant weight gain. The significantly decreased %L in the EEN versus NPO group might reflect improved gut barrier function, which could limit bacterial or endotoxin translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14658714      PMCID: PMC7166426          DOI: 10.1111/j.1939-1676.2003.tb02516.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  45 in total

Review 1.  The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease.

Authors:  D Hollander
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

2.  Differential sugar absorption for the assessment of canine intestinal permeability: the cellobiose/mannitol test in gluten-sensitive enteropathy of Irish setters.

Authors:  E J Hall; R M Batt
Journal:  Res Vet Sci       Date:  1991-07       Impact factor: 2.534

3.  Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber.

Authors:  Anne C Mosenthal; Dazhong Xu; Edwin A Deitch
Journal:  Crit Care Med       Date:  2002-02       Impact factor: 7.598

4.  A novel HPLC method for the simultaneous quantification of monosaccharides and disaccharides used in tests of intestinal function and permeability.

Authors:  S H Sørensen; F J Proud; A Adam; H C Rutgers; R M Batt
Journal:  Clin Chim Acta       Date:  1993-11-30       Impact factor: 3.786

5.  Abnormal intestinal permeability to sugars in villous atrophy.

Authors:  I S Menzies; M F Laker; R Pounder; J Bull; S Heyer; P G Wheeler; B Creamer
Journal:  Lancet       Date:  1979-11-24       Impact factor: 79.321

6.  Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units.

Authors:  J C Montejo
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

7.  Escherichia coli associated endotoxemia in dogs with parvovirus infection.

Authors:  E Isogai; H Isogai; M Onuma; N Mizukoshi; M Hayashi; S Namioka
Journal:  Nihon Juigaku Zasshi       Date:  1989-06

8.  Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis.

Authors:  P B Bijlsma; R A Peeters; J A Groot; P R Dekker; J A Taminiau; R Van Der Meer
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

Review 9.  Immediate enteral nutrition following multisystem trauma: a decade perspective.

Authors:  E E Moore; F A Moore
Journal:  J Am Coll Nutr       Date:  1991-12       Impact factor: 3.169

10.  Passive permeability in experimental intestinal damage in rats.

Authors:  I Cobden; J Rothwell; A T Axon
Journal:  Clin Sci (Lond)       Date:  1981-01       Impact factor: 6.124

View more
  12 in total

1.  Peptide YY induces enterocyte proliferation in a rat model with total enteral nutrition after distal bowel resection.

Authors:  Wei Zhang; Ning Li; Weiming Zhu; Yichao Shi; Jian Zhang; Qiurong Li; Jieshou Li
Journal:  Pediatr Surg Int       Date:  2008-05-30       Impact factor: 1.827

2.  The effect of short term peripheral parenteral nutrition on treatment outcomes and mortality in critically ill pediatric canine patients.

Authors:  Cesar Augusto Flores Dueñas; Soila Maribel Gaxiola Camacho; Martin Francisco Montaño Gómez; Rafael Villa Angulo; Idalia Enríquez Verdugo; Tomás Rentería Evangelista; José Ascención Pérez Corrales; Miguel Ángel Rodríguez Gaxiola
Journal:  Ir Vet J       Date:  2021-06-03       Impact factor: 2.146

3.  Evaluation of the Prevalence and Risk Factors for Undernutrition in Hospitalized Dogs.

Authors:  Jenifer Molina; Marta Hervera; Edgar Garcia Manzanilla; Carlos Torrente; Cecilia Villaverde
Journal:  Front Vet Sci       Date:  2018-08-29

Review 4.  Canine parvoviral enteritis: an update on the clinical diagnosis, treatment, and prevention.

Authors:  Mathios E Mylonakis; Iris Kalli; Timoleon S Rallis
Journal:  Vet Med (Auckl)       Date:  2016-07-11

5.  Changes in salivary analytes in canine parvovirus: A high-resolution quantitative proteomic study.

Authors:  Lorena Franco-Martínez; Asta Tvarijonaviciute; Anita Horvatić; Nicolas Guillemin; José Joaquín Cerón; Damián Escribano; David Eckersall; Meriç Kocatürk; Zeki Yilmaz; Elsa Lamy; Silvia Martínez-Subiela; Vladimir Mrljak
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2018-09-24       Impact factor: 2.268

Review 6.  Emesis in dogs: a review.

Authors:  C Elwood; P Devauchelle; J Elliott; V Freiche; A J German; M Gualtieri; E Hall; E den Hertog; R Neiger; D Peeters; X Roura; K Savary-Bataille
Journal:  J Small Anim Pract       Date:  2010-01       Impact factor: 1.522

7.  Serum D-lactate concentrations in dogs with parvoviral enteritis.

Authors:  Emilee C Venn; Alex J Barnes; Ryan J Hansen; Pedro L Boscan; David C Twedt; Lauren A Sullivan
Journal:  J Vet Intern Med       Date:  2020-01-10       Impact factor: 3.333

8.  Long-term effects of canine parvovirus infection in dogs.

Authors:  Elena Kilian; Jan S Suchodolski; Katrin Hartmann; Ralf S Mueller; Gerhard Wess; Stefan Unterer
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

Review 9.  Update on Canine Parvoviral Enteritis.

Authors:  Elisa M Mazzaferro
Journal:  Vet Clin North Am Small Anim Pract       Date:  2020-09-02       Impact factor: 2.093

Review 10.  Feline panleukopenia. ABCD guidelines on prevention and management.

Authors:  Uwe Truyen; Diane Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Tim Gruffydd-Jones; Katrin Hartmann; Margaret J Hosie; Albert Lloret; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Alan D Radford; Etienne Thiry; Marian C Horzinek
Journal:  J Feline Med Surg       Date:  2009-07       Impact factor: 2.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.